¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå
Antimicrobial Susceptibility Testing
»óǰÄÚµå : 1648869
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 382 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,171,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,515,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀåÀº 2030³â±îÁö 46¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 37¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀåÀº 2024-2030³â¿¡ CAGR 3.4%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 46¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¼öµ¿ Á¦Ç°Àº CAGR 3.6%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á±îÁö 15¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÚµ¿ °Ë»ç±â±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 3.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 9¾ï 9,610¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 6.7%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀåÀº 2024³â¿¡ 9¾ï 9,610¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀ» 6.7%·Î, 2030³â±îÁö 9¾ï 9,220¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 1.0%¿Í 2.3%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 1.6%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ç×±ÕÁ¦ °¨¼ö¼º ½ÃÇè ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Ç×±ÕÁ¦ °¨¼ö¼º °Ë»ç(AST)´Â ƯÁ¤ ¼¼±Õ º´¿ø±Õ¿¡ ´ëÇÑ Ç×»ýÁ¦ÀÇ È¿´ÉÀ» ÆÇ´ÜÇÏ´Â ¹Ì»ý¹°Çп¡¼­ ÇʼöÀûÀÎ °úÁ¤ÀÔ´Ï´Ù. ÀÌ Ä¡·á´Â ÀûÀýÇÑ Ç×»ýÁ¦ Ä¡·á¸¦ À¯µµÇϰí ÀÓ»óÀǰ¡ °¨¿°¿¡ °¡Àå È¿°úÀûÀÎ Ä¡·á¹ýÀ» ¼±ÅÃÇÒ ¼ö ÀÖµµ·Ï ÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇϸç, AST´Â µð½ºÅ© È®»ê¹ý, ±¹¹° ¹Ì·® Èñ¼®¹ý, ÀÚµ¿È­ ½Ã½ºÅÛ µî ´Ù¾çÇÑ ¹æ¹ýÀ» »ç¿ëÇÏ¿© ¼öÇàµË´Ï´Ù. °¢ ¹æ¹ýÀº ¹ÚÅ׸®¾Æ¸¦ ´Ù¾çÇÑ ³óµµÀÇ Ç×»ýÁ¦¿¡ ³ëÃâ½ÃÄÑ ¹ÚÅ׸®¾ÆÀÇ Áõ½Ä ÆÐÅÏÀ» °üÂûÇÕ´Ï´Ù. ±× °á°ú, ¹ÚÅ׸®¾Æ°¡ Å×½ºÆ®ÇÑ Ç×»ýÁ¦¿¡ ¹Î°¨, Áß°£, ³»¼º Áß ¾î´À ÂÊ¿¡ ¼ÓÇÏ´ÂÁö ¾Ë ¼ö ÀÖ½À´Ï´Ù.

ASTÀÇ Á߿伺Àº °øÁß º¸°Ç¿¡ ½É°¢ÇÑ À§ÇùÀÌ µÇ´Â Ç×»ýÁ¦ ³»¼º ¹ÚÅ׸®¾Æ Áõ°¡¿Í ÇÔ²² Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¤È®ÇÏ°í ½Ã±âÀûÀýÇÑ °¨¼ö¼º °Ë»ç´Â ±âÁ¸ Ç×»ýÁ¦ÀÇ ÀûÀýÇÑ »ç¿ëÀ» º¸ÀåÇÔÀ¸·Î½á ³»¼º±ÕÀÇ È®»êÀ» ´ÊÃß´Â µ¥ µµ¿òÀÌ µÇ¸ç, AST ±â¼úÀÇ ¹ßÀüÀ¸·Î °Ë»ç °á°úÀÇ ¼Óµµ¿Í Á¤È®µµ°¡ Çâ»óµÇ¾ú½À´Ï´Ù. ÀÚµ¿È­µÈ ½Ã½ºÅÛ°ú PCR ¹× Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®°ú °°Àº ºÐÀÚ»ý¹°ÇÐÀû ¹æ¹ýÀ» ÅëÇØ ³»¼º À¯ÀüÀÚ¸¦ ½Å¼ÓÇÏ°Ô °ËÃâÇÏ°í ¼¼±Õ º´¿øÃ¼¿¡ ´ëÇÑ ´õ ÀÚ¼¼ÇÑ Á¤º¸¸¦ ¾òÀ» ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú ¹ßÀüÀº ASTÀÇ È¿À²¼ºÀ» ³ô¿© ´õ ºü¸¥ ÀÓ»óÀû ÀÇ»ç°áÁ¤°ú ´õ ³ªÀº ȯÀÚ °á°ú¸¦ °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù.

Ç×±ÕÁ¦ °¨¼ö¼º Å×½ºÆ® ½ÃÀåÀÇ ¼ºÀåÀº ¿©·¯ °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. Ç×»ýÁ¦ ³»¼º °¨¿° Áõ°¡°¡ ÁÖ¿ä ¿äÀÎÀ¸·Î, ´õ ºó¹øÇϰí Á¾ÇÕÀûÀÎ °Ë»ç°¡ ÇÊ¿äÇÕ´Ï´Ù. ³»¼º±ÕÀÇ È®»êÀ» ¾ïÁ¦Çϰí Ç×»ýÁ¦ »ç¿ëÀ» °³¼±Çϱâ À§ÇÑ Á¤ºÎÀÇ ±¸»ó°ú ±ÔÁ¦µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÇ·á ȯ°æ¿¡¼­ ½Å¼ÓÇϰí Á¤È®ÇÑ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó °í±Þ AST ¹æ¹ýÀÇ Ã¤ÅÃÀÌ °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù. ÀÓ»ó ½ÇÇè½ÇÀÇ È®Àå ¹× R&D¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡µµ ½ÃÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿äÀεéÀº È¿°úÀûÀÎ °¨¿° ¿¹¹æ¿¡ ´ëÇÑ Áö¼ÓÀûÀÎ ¿ä±¸¿Í ÇÔ²² Ç×±ÕÁ¦ °¨¼ö¼º °Ë»ç ½ÃÀåÀÇ °­·ÂÇÑ ¼ºÀå ±Ëµµ¸¦ º¸ÀåÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(Ç×±Õ, Ç×Áø±Õ, Ç×Áø±Õ, Ç×±â»ýÃæ, ±âŸ °Ë»ç À¯Çü)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ ÇÕ°è 52»ç)

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Antimicrobial Susceptibility Testing Market to Reach US$4.6 Billion by 2030

The global market for Antimicrobial Susceptibility Testing estimated at US$3.7 Billion in the year 2024, is expected to reach US$4.6 Billion by 2030, growing at a CAGR of 3.4% over the analysis period 2024-2030. Manual Products, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$1.5 Billion by the end of the analysis period. Growth in the Automated Laboratory Instruments segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$996.1 Million While China is Forecast to Grow at 6.7% CAGR

The Antimicrobial Susceptibility Testing market in the U.S. is estimated at US$996.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$992.2 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.6% CAGR.

Global Antimicrobial Susceptibility Testing Market - Key Trends & Drivers Summarized

Antimicrobial Susceptibility Testing (AST) is an essential process in microbiology that determines the effectiveness of antibiotics against specific bacterial pathogens. This testing is critical for guiding appropriate antibiotic therapy, helping clinicians choose the most effective treatment for infections. AST is performed using various methods, including disk diffusion, broth microdilution, and automated systems. Each method involves exposing the bacteria to different concentrations of antibiotics and observing their growth patterns. The results indicate whether the bacteria are susceptible, intermediate, or resistant to the antibiotics tested, which is vital information for treating infections and combating antibiotic resistance.

The importance of AST has increased with the rise of antibiotic-resistant bacteria, which pose a significant public health threat. Accurate and timely susceptibility testing helps in the stewardship of existing antibiotics by ensuring their appropriate use, thereby slowing the spread of resistance. Advances in AST technology have improved the speed and accuracy of results. Automated systems and molecular methods, such as PCR and next-generation sequencing, allow for rapid detection of resistance genes and provide more detailed information about bacterial pathogens. These technological advancements have made AST more efficient, enabling faster clinical decision-making and better patient outcomes.

The growth in the antimicrobial susceptibility testing market is driven by several factors. The increasing prevalence of antibiotic-resistant infections is a primary driver, necessitating more frequent and comprehensive testing. Government initiatives and regulations aimed at controlling the spread of resistance and improving antibiotic use are also contributing to market growth. Additionally, the growing demand for rapid and accurate diagnostic tools in healthcare settings has spurred the adoption of advanced AST methods. The expansion of clinical laboratories and the rising investment in research and development further support the market. These factors, combined with the ongoing need for effective infection control measures, ensure a strong growth trajectory for the antimicrobial susceptibility testing market.

SCOPE OF STUDY:

The report analyzes the Antimicrobial Susceptibility Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Manual Products, Automated Laboratory Instruments, Culture & Growth Media, Consumables); Testing Type (Antibacterial, Antifungal, Antiparasitic, Other Testing Types)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 52 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â